Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fispemifene for sexual dysfunction in hypogonadal men
NCT02443090Phase 2Unknown
- Sponsor
- Apricus Biosciences, Inc.
- Start
- May 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fispemifene in secondary hypogonadism (HH), erectile dysfunction (ED), sponsored by Apricus Biosciences, Inc.. Status: unknown.
02
Drugs
fispemifene
03
Conditions
secondary hypogonadism (HH)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02443090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443090.